Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Open in API
Filings indexed 761 across all filing types
Latest filing 2011-09-01 Board/Management Inform…
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Michael Sundström appointed as Vice President Discovery Research of Karolinska Development and CEO of Actar
Board/Management Information Classification · 1% confidence The document is an announcement detailing the appointment of Michael Sundström as Vice President Discovery Research of Karolinska Development and CEO of Actar. This involves a change in senior management personnel. According to the definitions, announcements of changes in the company's board of directors or senior management fall under the 'Board/Management Information' category.
2011-09-01 English
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Delårsrapport januari – juni 2011' (Interim Report January – June 2011) for Karolinska Development AB. It contains comprehensive financial statements, including income statements, balance sheet summaries, and management commentary on financial performance, business trends, and outlook for the specified period. It is not an announcement of a report, but the report itself, and it contains substantive financial data, fitting the definition of an Interim/Quarterly Report. H1 2011
2011-08-25 Swedish
Interim / Quarterly Report 2011
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January – June 2011' and contains comprehensive financial statements, including a consolidated income statement, balance sheet data, and management commentary on business performance and risks. It is clearly a periodic financial report for a duration shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2011
2011-08-25 English
Karolinska Development - Delårsrapport januari - juni, inbjudan till telefonkonferens torsdagen den 25 augusti
Report Publication Announcement Classification · 1% confidence The document is a short announcement (2160 characters) dated August 22, 2011, stating that Karolinska Development will publish its interim report ('Delårsrapport') for January - June 2011 on August 25th and invites participants to a conference call on the same day. Since the text is an announcement about the upcoming release of a periodic financial report (Interim Report) and includes details for an associated conference call, it fits the definition of a Report Publication Announcement (RPA) or potentially an Earnings Release (ER) if it contained the actual results. However, given the explicit focus on *announcing* the publication date and the conference call details, RPA is the most precise fit according to Rule 2 ('MENU VS MEAL' rule). The content is not the comprehensive report itself (which would be an IR).
2011-08-22 Swedish
Karolinska Development - Interim report January - June, conference call Thursday, August 25
Report Publication Announcement Classification · 1% confidence The document explicitly announces the publication date and time for the 'interim report for January - June 2011' and also announces a subsequent conference call. The key phrase is 'Karolinska Development will publish its interim report for January - June 2011'. An interim report covering a period shorter than a year (January - June) corresponds to the Interim / Quarterly Report (IR) definition. However, the document itself is not the report; it is an announcement *about* the report's publication and the associated conference call. Since the document is short (2137 chars) and its primary function is to state when the report will be available and to announce the call, it fits the description of a Report Publication Announcement (RPA) or potentially a Call Transcript (CT) if the call details were the main focus, but the report announcement precedes the call details. Given the structure, it is an announcement of a forthcoming report, making RPA the most appropriate classification based on Rule 2 (Menu vs Meal). If the document contained the full interim report data, it would be IR. Since it only announces the publication, RPA is selected.
2011-08-22 English
Axelar rapporterar avslutad säkerhetsstudie i fas I/II med AXL1717 för cancerpatienter
Regulatory Filings Classification · 1% confidence The document is a press release from Axelar AB (a portfolio company of Karolinska Development) announcing the completion of a Phase I/II clinical safety study for their drug candidate AXL1717. It details the study's conclusion, mentions preliminary results will be presented at an upcoming conference (ESMO), and outlines plans for a future Phase II program. This type of announcement, focusing on clinical trial milestones and future data presentation, is characteristic of an early-stage biotechnology company communicating progress to investors and the public. It is not a full Annual Report (10-K), a formal Audit Report (AR), a Dividend Notice (DIV), or a formal Earnings Release (ER) which typically focuses on revenue/profit. Since it is a specific announcement about clinical progress and future data release, it fits best under general Regulatory Filings (RNS) as a broad category for corporate updates that don't fit the highly specific financial/governance codes, or potentially an Investor Presentation (IP) if it were a slide deck, but as a press release detailing trial status, RNS is the most appropriate general category for non-standard corporate news.
2011-07-07 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.